WELCOME TO THE

ADD-ASPIRIN WEBSITE

This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.           

Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.

Congratulations to our top 5 recruiting centres:
1. Bristol Haematology & Oncology Centre
2. Worcestershire Royal Hospital
3. University Hospitals Coventry & Warwickshire
4. Royal Marsden Hopsital
5. Royal Cornwall Hospital

News

Summer 2016
MRC CTU at UCL will be hosting a series of regional Urological Trials Meetings for investigators and research teams.
Read more

April 2016
Add-Aspirin recruits its 500th patient!

April 2016
Telegraph: Daily aspirin recommended in US but still not in Britain.
Read more

February 2016
World Cancer Day 2016
Read more

October 2015
Add-Aspirin trial is now open!

Quick links for
NHS professionals


REGISTER A PARTICIPANT

To RANDOMISE a participant please call +44 (0)20 7670 4777

UNBLIND A PARTICIPANT

 

BREAST


We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here   

 

PARTICIPANTS REGISTERED: 285
PARTICIPANTS RANDOMISED: 138
   

COLON/RECTUM 


We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

 

PARTICIPANTS REGISTERED: 139
PARTICIPANTS RANDOMISED: 77

STOMACH/OESOPHAGUS 


We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

PARTICIPANTS REGISTERED: 21
PARTICIPANTS RANDOMISED: 6

PROSTATE


We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here    

                                              PARTICIPANTS REGISTERED: 121
PARTICIPANTS RANDOMISED: 62
     

The trial is being jointly funded by Cancer Research UK (grant number C471 /A15015, www.cancerresearchuk.org), the National Institute for Health Research Health Technology Assessment Programme (project number 12/01/38, www.nihr.ac.uk) and the MRC Clinical Trials Unit at UCL.
© Add-Aspirin, MRC CTU at UCL